Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.130
+0.090 (8.65%)
At close: Apr 2, 2025, 4:00 PM
1.139
+0.009 (0.81%)
After-hours: Apr 2, 2025, 6:07 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $21.31 million as of April 2, 2025. Its market cap has increased by 87.67% in one year.
Market Cap
21.31M
Enterprise Value
8.12M
1-Year Change
87.67%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $21.31M, a decrease of -96.62%. That is a compound annual growth rate of -56.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 19.61M | -42.54% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.69B |
| UnitedHealth Group | 478.41B |
| Johnson & Johnson | 372.82B |
| AbbVie | 362.16B |
| Novo Nordisk | 307.98B |
| Abbott Laboratories | 228.46B |
| AstraZeneca | 227.81B |
| Merck & Co. | 217.37B |